Factors affecting sexual transmission of HIV-1: Current evidence and implications for prevention

Current HIV Research

Volumn 3, Issue 3, 2005, Pages 223-241

  Chan, Derek J ^a  

^a Albion Street Centre ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; AZITHROMYCIN; BENZATHINE PENICILLIN; CHEMOKINE RECEPTOR CCR5; CIPROFLOXACIN; HLA ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; METRONIDAZOLE; NONOXINOL 9; ORAL CONTRACEPTIVE AGENT; PROTEINASE INHIBITOR; RETINOL; SELENIUM; SPERMICIDAL AGENT; TENOFOVIR; ZIDOVUDINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CANDIDA; CANDIDIASIS; CHLAMYDIA; CHLAMYDIASIS; CIRCUMCISION; CLADISTICS; CONDOM; DEVELOPED COUNTRY; DEVELOPING COUNTRY; EPIDEMIC; EVIDENCE BASED MEDICINE; FEMALE; FINANCIAL MANAGEMENT; GENITAL HERPES; GONORRHEA; GRANULOMA INGUINALE; HAEMOPHILUS DUCREYI; HEALTH PROMOTION; HERPES SIMPLEX VIRUS 2; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; INFECTION SENSITIVITY; LYMPHOGRANULOMA VENEREUM; MALE; NEISSERIA GONORRHOEAE; NUTRITIONAL DEFICIENCY; PATIENT COMPLIANCE; PREVENTIVE MEDICINE; PROSTITUTION; PUBLIC HEALTH SERVICE; RESOURCE ALLOCATION; RETINOL DEFICIENCY; REVIEW; RISK ASSESSMENT; SELENIUM DEFICIENCY; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TREPONEMA PALLIDUM; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; ULCUS MOLLE; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS SHEDDING;

ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; VIREMIA;

EID: 22944453688     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570162054368075     Document Type: Review

References (314)

1. AIDS epidemic update December 2004. (2004), Joint United Nations Programme on HIV/AIDS (UNAIDS), World Health Organization (WHO): Geneva.
2. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. (1996). CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272: 1955-1958.
3. Anderson DJ, O'Brien TR, Politch JA, Martinez A, Seage GR, 3rd, Padian N, Horsburgh CR, Jr, Mayer KH. (1992). Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. JAMA. 267: 2769-2774.
4. Anderson RM, May RM, Boily MC, Garnett GP, Rowley JT. (1991). The spread of HIV-1 in Africa: sexual contact patterns and the predicted demographic impact of AIDS. Nature. 352: 581-589.
5. Araneta MR, Mascola L, Eller A, O'Neil L, Ginsberg MM, Bursaw M, Marik J, Friedman S, Sims CA, Rekart ML, Collie F. (1995). HIV transmission through donor artificial insemination. JAMA. 273: 854-858.
6. Avonts D, Sercu M, Heyerick P, Vandermeeren I, Meheus A, Piot P. (1990). Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study. Sexually Transmitted Diseases. 17: 23-29.
7. Baba TW, Trichel AM, An L, Liska V, Martin LN, Murphey-Corb M, Ruprecht RM. (1996). Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. Science. 272: 1486-1489.
8. Ball JK, Rowe T, Curran R, Irving WL, Beards GM, Sontag G, Youle M, Moyle G, Pillay D. (1999). Poor reduction of HIV-1 RNA titres in nucleoside reverse transcriptase inhibitor experienced patients treated with indinavir combination therapy. Sexually Transmitted Infections. 75: 337-339.
9. Barbour JD, Hecht FM, Wrin T, Liegler TJ, Ramstead CA, Busch MP, Segal MR, Petropoulos CJ, Grant RM. (2004). Persistence of primary drug resistance among recently HIV-1 infected adults. AIDS. 18: 1683-1689.
10. Barroso PF, Schechter M, Gupta P, Melo MF, Vieira M, Murta FC, Souza Y, Harrison LH. (2000). Effect of antiretroviral therapy on HIV shedding in semen. Annals of Internal Medicine. 133: 280-284.
11. Baruchel S, Wainberg MA. (1992). The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. Journal of Leukocyte Biology. 52: 111-114.
12. Baum MK, Shor-Posner G, Lu Y, Rosner B, Sauberlich HE, Fletcher MA, Szapocznik J, Eisdorfer C, Buring JE, Hennekens CH. (1995). Micronutrients and HIV-1 disease progression. AIDS. 9: 1051-1056.
13. Baylis F, Ginn D. (1998). Expanding access to PEP: ethical and legal issues. AIDS Public Policy Journal. 13: 140-167.
14. Benedetti JK, Zeh J, Corey L. (1999). Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Annals of Internal Medicine. 131: 14-20.
15. Benki S, Mostad SB, Richardson BA, Mandaliya K, Kreiss JK, Overbaugh J. (2004). Cyclic shedding of HIV-1 RNA in cervical secretions during the menstrual cycle. Journal of Infectious Diseases. 189: 2192-2201.
16. Bentwich Z, Maartens G, Torten D, Lal AA, Lal RB. (2000). Concurrent infections and HIV pathogenesis. AIDS. 14: 2071-2081.
17. Berger EA, Doms RW, Fenyo EM, Korber BT, Littman DR, Moore JP, Sattentau QJ, Schuitemaker H, Sodroski J, Weiss RA. (1998). A new classification for HIV-1. Nature. 391: 240.
18. Berkeley AS, Micha JP, Freedman KS, Hirsch JC. (1985). The potential of digitally inserted tampons to induce vaginal lesions. Obstetrics and Gynecology. 66: 31-35.
19. Bernard NF, Yannakis CM, Lee JS, Tsoukas CM. (1999). Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons. Journal of Infectious Diseases. 179: 538-547.
20. Blower SM, Gershengorn HB, Grant RM. (2000). A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science. 287: 650-654.
21. Bourlet T, Cazorla C, Berthelot P, Grattard F, Cognasse F, Fresard A, Defontaine C, Lucht FR, Genin C, Pozzetto B. (2001). Compartmentalization of HIV-1 according to antiretroviral therapy: viral loads are correlated in blood and semen but poorly in blood and saliva. AIDS. 15: 284-285.
22. Braathen LR, Ramirez G, Kunze RO, Gelderblom H. (1987). Langerhans cells as primary target cells for HIV infection. Lancet. 2: 1094.
23. Brown JE, Ayowa OB, Brown RC. (1993). Dry and tight: sexual practices and potential AIDS risk in Zaire. Social Science & Medicine. 37: 989-994.
24. Buchacz K, Patel P, Taylor M, Kerndt PR, Byers RH, Holmberg SD, Klausner JD. (2004). Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS. 18: 2075-2079.
25. Caceres CF, van Griensven GJ. (1994). Male homosexual transmission of HIV-1. AIDS. 8: 1051-1061.
26. Cameron DW, Simonsen JN, D'Costa LJ, Ronald AR, Maitha GM, Gakinya MN, Cheang M, Ndinya-Achola JO, Piot P, Brunham RC. (1989). Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet. 2: 403-407.
27. Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, Heptonstall J, Ippolito G, Lot F, McKibben PS, Bell DM. (1997). A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. New England Journal of Medicine. 337: 1485-1490.
28. Case-control study of HIV seroconversion in healthcare workers after percutaneous exposure to HIV-infected blood:France, United Kingdom and United States, January 1988-August 1994.(1995). Morbidity and Mortality Weekly Report. 44: 929.
29. Cates W. (1997). In World Health Organization Scientific Review Committee Meeting: Geneva, Switzerland.
30. Cates W, Jr, Chesney MA, Cohen MS. (1997). Primary HIV infection - a public health opportunity. American Journal of Public Health. 87: 1928-1930.
31. Celum CL, Buchbinder SP, Donnell D, Douglas JM, Jr., Mayer K, Koblin B, Marmor M, Bozeman S, Grant RM, Flores J, Sheppard HW. (2001). Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load. Journal of Infectious Diseases. 183: 23-35.
32. Chakraborty H, Sen PK, Helms RW, Vernazza PL, Fiscus SA, Eron JJ, Patterson BK, Coombs RW, Krieger JN, Cohen MS. (2001). Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS. 15: 621-627.
33. Chen CY, Ballard RC, Beck-Sague CM, Dangor Y, Radebe F, Schmid S, Weiss JB, Tshabalala V, Fehler G, Htun Y, Morse SA. (2000). Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection. Sexually Transmitted Diseases. 27: 21-29.
34. Chmiel JS, Detels R, Kaslow RA, Van Raden M, Kingsley LA, Brookmeyer R. (1987). Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. American Journal of Epidemiology. 126: 568-577.
35. Clark SJ, Saag MS, Decker WD, Campbell-Hill S, Roberson JL, Veldkamp PJ, Kappes JC, Hahn BH, Shaw GM. (1991). High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. New England Journal of Medicine. 324: 954-960.
36. Clemetson DB, Moss GB, Willerford DM, Hensel M, Emonyi W, Holmes KK, Plummer F, Ndinya-Achola J, Roberts PL, Hillier S. (1993). Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA. 269: 2860-2864.
37. Clumeck N, Taelman H, Hermans P, Piot P, Schoumacher M, De Wit S. (1989). A cluster of HIV infection among heterosexual people without apparent risk factors. New England Journal of Medicine. 321: 1460-1462.
38. Coates RA, Calzavara LM, Read SE, Fanning MM, Shepherd FA, Klein MH, Johnson JK, Soskolne CL. (1988). Risk factors for HIV infection in male sexual contacts of men with AIDS or an AIDS-related condition. American Journal of Epidemiology. 128: 729-739.
39. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. (1995). Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 270: 1811-1815.
40. Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR, Daly CC, Zimba D, Vernazza PL, Maida M, Fiscus SA, Eron JJ, Jr. (1997). Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet. 349: 1868-1873.
41. Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV.(1992). BMJ. 304: 809-813.
42. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, Jimenez E, O'Neill E, Bazin B, Delfraissy J, Culnane M, Coombs R, Elkins M, Moye J, Stratton P, Balsley J. (1994). Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. New England Journal of Medicine. 331: 1173-1180.
43. Coombs RW, Reichelderfer PS, Landay AL. (2003). Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS. 17: 455-480.
44. Coombs RW, Speck CE, Hughes JP, Lee W, Sampoleo R, Ross SO, Dragavon J, Peterson G, Hooton TM, Collier AC, Corey L, Koutsky L, Krieger JN. (1998). Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. Journal of Infectious Diseases. 177: 320-330.
45. Coombs RW, Wright DJ, Reichelderfer PS, Burns DN, Cohn J, Cu-Uvin S, Baron PA, Cohen MH, Landay AL, Lewis S, Kovacs A. (2001). Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women. Journal of Infectious Diseases. 184: 1187-1191.
46. Copeland KF, McKay PJ, Rosenthal KL. (1995). Suppression of activation of the human immunodeficiency virus long terminal repeat by CD8+ T cells is not lentivirus specific. AIDS Research and Human Retroviruses. 11: 1321-1326.
47. Corey L, Wald A, Celum CL, Quinn TC. (2004). The Effects of Herpes Simplex Virus-2 on HIV-1 Acquisition and Transmission: A Review of Two Overlapping Epidemics. Journal of Acquired Immune Deficiency Syndromes. 35: 435-445.
48. Coutsoudis A, Moodley D, Pillay K, Harrigan R, Stone C, Moodley J, Coovadia HM. (1997). Effects of vitamin A supplementation on viral load in HIV-1-infected pregnant women. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 15: 86-87.
49. Craib KJ, Meddings DR, Strathdee SA, Hogg RS, Montaner JS, O'Shaughnessy MV, Schechter MT. (1995). Rectal gonorrhoea as an independent risk factor for HIV infection in a cohort of homosexual men. Genitourinary Medicine. 71: 150-154.
50. Cu-Uvin S, Caliendo AM, Reinert S, Chang A, Juliano-Remollino C, Flanigan TP, Mayer KH, Carpenter CC. (2000). Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS. 14: 415-421.
51. Cu-Uvin S, Hogan JW, Caliendo AM, Harwell J, Mayer KH, Carpenter CC. (2001). Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clinical Infectious Diseases. 33: 894-896.
52. Daar ES, Moudgil T, Meyer RD, Ho DD. (1991). Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. New England Journal of Medicine. 324: 961-964.
53. Dallabetta GA, Miotti PG, Chiphangwi JD, Liomba G, Canner JK, Saah AJ. (1995). Traditional vaginal agents: use and association with HIV infection in Malawian women. AIDS. 9: 293-297.
54. Darrow WW, Echenberg DF, Jaffe HW, O'Malley PM, Byers RH, Getchell JP, Curran JW. (1987). Risk factors for human immunodeficiency virus (HIV) infections in homosexual men. American Journal of Public Health. 77: 479-483.
55. de Ronde A, van Dooren M, van Der Hoek L, Bouwhuis D, de Rooij E, van Gemen B, de Boer R, Goudsmit J. (2001). Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus. Journal of Virology. 75: 595-602.
56. de Vincenzi I. (1994). A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. New England Journal of Medicine. 331: 341-346.
57. de Vincenzi I, Mertens T. (1994). Male circumcision: a role in HIV prevention? AIDS. 8: 153-160.
58. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O'Brien SJ. (1996). Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 273: 1856-1862.
59. Debiaggi M, Zara F, Spinillo A, De Santolo A, Maserati R, Bruno R, Sacchi P, Achilli G, Pistorio A, Romero E, Filice G. (2001). Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy. European Journal of Clinical Microbiology & Infectious Diseases 20: 91-96.
60. DeGruttola V, Mayer KH. (1987). Human immunodeficiency virus and oral intercourse. Annals of Internal Medicine. 107: 428-429.
61. del Mar Pujades Rodriguez M, Obasi A, Mosha F, Todd J, Brown D, Changalucha J, Mabey D, Ross D, Grosskurth H, Hayes R. (2002). Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS. 16: 451-462.
62. del Romero J, Marincovich B, Castilla J, Garcia S, Campo J, Hernando V, Rodriguez C. (2002). Evaluating the risk of HIV transmission through unprotected orogenital sex. AIDS. 16: 1296-1297.
63. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR. (1996). Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381: 661-666.
64. Desmond NM, Coker RJ. (1998). Should preventive antiretroviral treatment be offered following sexual exposure to HIV? The case for. Sexually Transmitted Infections. 74: 144-145.
65. Di Stefano M, Favia A, Monno L, Lopalco P, Caputi O, Scardigno AC, Pastore G, Fiore JR, Angarano G. (2001). Intracellular and cell-free (infectious) HIV-1 in rectal mucosa. Journal of Medical Virology. 65: 637-643.
66. Doncel GF, Chandra N, Fichorova RN. (2004). Preclinical assessment of the proinflammatory potential of microbicide candidates. Journal of Acquired Immune Deficiency Syndromes. 37.
67. Donovan B, Tindall B, Cooper D. (1986). Brachioproctic eroticism and transmission of retrovirus associated with acquired immune deficiency syndrome (AIDS). Genitourinary Medicine. 62: 390-392.
68. Dornadula G, Zhang H, VanUitert B, Stern J, Livornese L, Jr., Ingerman MJ, Witek J, Kedanis RJ, Natkin J, DeSimone J, Pomerantz RJ. (1999). Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. JAMA. 282: 1627-1632.
69. Downs AM, De Vincenzi I. (1996). Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. European Study Group in Heterosexual Transmission of HIV. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 11: 388-395.
70. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA. (1996). HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381: 667-673.
71. Dyer JR, Eron JJ, Hoffman IF, Kazembe P, Vernazza PL, Nkata E, Costello Daly C, Fiscus SA, Cohen MS. (1998). Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi. Journal of Infectious Diseases. 177: 224-227.
72. Eron JJ, Jr, Smeaton LM, Fiscus SA, Gulick RM, Currier JS, Lennox JL, D'Aquila RT, Rogers MD, Tung R, Murphy RL. (2000). The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850). Journal of Infectious Diseases. 181: 1622-1628.
73. Fahey JV, Wira CR. (2002). Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. Journal of Infectious Diseases. 185: 1606-1613.
74. Farber CM, Barath AA, Dieye T. (1996). The effects of immunization in human immunodeficiency virus type 1 infection. New England Journal of Medicine. 335: 817; author reply 818-819.
75. Feng Y, Broder CC, Kennedy PE, Berger EA. (1996). HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272: 872-877.
76. Figueroa JP, Brathwaite A, Morris J, Ward E, Peruga A, Blattner W, Vermund SH, Hayes R. (1994). Rising HIV-1 prevalence among sexually transmitted disease clinic attenders in Jamaica: traumatic sex and genital ulcers as risk factors. Journal of Acquired Immune Deficiency Syndromes. 7: 310-316.
77. Fischl MA, Dickinson GM, Scott GB, Klimas N, Fletcher MA, Parks W. (1987). Evaluation of heterosexual partners, children, and household contacts of adults with AIDS. JAMA. 257: 640-644.
78. Fleming DT, Wasserheit JN. (1999). From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sexually Transmitted Infections. 75: 3-17.
79. Furci L, Lopalco L, Loverro P, Sinnone M, Tambussi G, Lazzarin A, Lusso P. (2002). Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individuals, AIDS. 16: 1003-1008.
80. Furci L, Scarlatti G, Burastero S, Tambussi G, Colognesi C, Quillent C, Longhi R, Loverro P, Borgonovo B, Gaffi D, Carrow E, Malnati M, Lusso P, Siccardi AG, Lazzarin A, Beretta A. (1997). Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele. The Journal of Experimental Medicine. 186: 455-460.
81. Gadkari DA, Quinn TC, Gangakhedkar RR, Mehendale SM, Divekar AD, Risbud AR, Chan-Tack K, Shepherd M, Gaydos C, Bollinger RC. (1998). HIV-1 DNA shedding in genital ulcers and its associated risk factors in Pune, India. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 18: 277-281.
82. Garber DA, Silvestri G, Feinberg MB. (2004). Prospects for an AIDS vaccine: three big questions, no easy answers. Lancet Infectious Diseases. 4: 397-413.
83. Garnett GP, Anderson RM. (1996). Antiviral therapy and the transmission dynamics of HIV-1. Journal of Antimicrobial Chemotherapy. 37 Suppl B: 135-150.
84. Ghosn J, Viard JP, Katlama C, de Almeida M, Tubiana R, Letourneur F, Aaron L, Goujard C, Salmon D, Leruez-Ville M, Rouzioux C, Chaix ML. (2004). Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men. AIDS. 18: 447-457.
85. Gilliam BL, Dyer JR, Fiscus SA, Marcus C, Zhou S, Wathen L, Freimuth WW, Cohen MS, Eron JJ, Jr. (1997). Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 15: 54-60.
86. Gilson L, Mkanje R, Grosskurth H, Mosha F, Picard J, Gavyole A, Todd J, Mayaud P, Swai R, Fransen L, Mabey D, Mills A, Hayes R. (1997). Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet. 350: 1805-1809.
87. Goedert JJ, Eyster ME, Biggar RJ, Blattner WA. (1987). Heterosexual transmission of human immunodeficiency virus: association with severe depletion of T-helper lymphocytes in men with hemophilia. AIDS Research and Human Retroviruses. 3: 355-361.
88. Goldberg DJ, Green ST, Kennedy DH, Emslie JA, Black JD. (1988). HIV and orogenital transmission. Lancet. 2: 1363.
89. Goletti D, Weissman D, Jackson RW, Graham NM, Vlahov D, Klein RS, Munsiff SS, Ortona L, Cauda R, Fauci AS. (1996). Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. Journal of Immunology. 157: 1271-1278.
90. Gray RH, Kiwanuka N, Quinn TC, Sewankambo NK, Serwadda D, Mangen FW, Lutalo T, Nalugoda F, Kelly R, Meehan M, Chen MZ, Li C, Wawer MJ. (2000). Male circumcision and HIV acquisition and transmission cohort studies in Rakai, Uganda. Rakai Project Team. AIDS. 14: 2371-2381.
91. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, Lutalo T, Li X, vanCott T, Quinn TC. (2001). Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 357: 1149-1153.
92. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, Mayaud P, Changalucha J, Nicoll A, ka-Gina G, Newell J, Mabey D, Hayes R, Mugeye K. (1995). Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 346: 530-536.
93. Guimaraes MD, Munoz A, Boschi-Pinto C, Castilho EA. (1995). HIV infection among female partners of seropositive men in Brazil. Rio de Janeiro Heterosexual Study Group. American Journal of Epidemiology. 142: 538-547.
94. Gupta P, Mellors J, Kingsley L, Riddler S, Singh MK, Schreiber S, Cronin M, Rinaldo CR. (1997). High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. Journal of Virology. 71: 6271-6275.
95. Gwanzura L, McFarland W, Alexander D, Burke RL, Katzenstein D. (1998). Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe. Journal of Infectious Diseases. 177: 481-484.
96. Halperin DT, Bailey RC. (1999). Male circumcision and HIV infection: 10 years and counting. Lancet. 354: 1813-1815.
97. Halperin DT, Weiss HA, Hayes R, Auvert B, Bailey RC, Caldwell J, Coates T, Padian N, Potts M, Ronald A, Short R, Williams B, Klausner J. (2002). Response to Ronald Gray, Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda (2000, 14:2371-2381). AIDS. 16: 810-812; author reply 809-810.
98. Hamed KA, Winters MA, Holodniy M, Katzenstein DA, Merigan TC. (1993). Detection of human immunodeficiency virus type 1 in semen: effects of disease stage and nucleoside therapy. Journal of Infectious Diseases. 167: 798-802.
99. Hart CE, Lennox JL, Pratt-Palmore M, Wright TC, Schinazi RF, Evans-Strickfaden T, Bush TJ, Schnell C, Conley LJ, Clancy KA, Ellerbrock TV. (1999). Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. Journal of Infectious Diseases. 179: 871-882.
100. Henin Y, Mandelbrot L, Henrion R, Pradinaud R, Coulaud JP, Montagnier L. (1993). Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. Journal of Acquired Immune Deficiency Syndromes. 6: 72-75.
101. Hicks DR, Martin LS, Getchell JP, Heath JL, Francis DP, McDougal JS, Curran JW, Voeller B. (1995). Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. Lancet. 2: 1422-1423.
102. Hira SK, Mangrola UG, Mwale C, Chintu C, Tembo G, Brady WE, Perine PL. (1990). Apparent vertical transmission of human immunodeficiency virus type 1 by breast-feeding in Zambia. The Journal of Pediatrics. 117: 421-424.
103. Hladik F, Lentz G, Akridge RE, Peterson G, Kelley H, McElroy A, McElrath MJ. (1999). Dendritic cell-T-cell interactions support coreceptor-independent human immunodeficiency virus type 1 transmission in the human genital tract. Journal of Virology. 73: 5833-5842.
104. Ho DD. (1995). Time to hit HIV, early and hard. New England Journal of Medicine. 333: 450-451.
105. Ho JL, He S, Hu A, Geng J, Basile FG, Almeida MG, Saito AY, Laurence J, Johnson WD, Jr. (1995). Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis. The Journal of Experimental Medicine. 181: 1493-1505.
106. Hocini H, Becquart P, Bouhlal H, Chomont N, Ancuta P, Kazatchkine MD, Belec L. (2001). Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cells. Journal of Virology. 75: 5370-5374.
107. Hoffman TL, Doms RW. (1998). Chemokines and coreceptors in HIV/SIV-host interactions. AIDS. 12 Suppl A: S17-26.
108. Holmberg SD, Stewart JA, Gerber AR, Byers RH, Lee FK, O'Malley PM, Nahmias AJ. (1988). Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA. 259: 1048-1050.
109. Hook EW, 3rd, Cannon RO, Nahmias AJ, Lee FF, Campbell CH, Jr., Glasser D, Quinn TC. (1992). Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. Journal of Infectious Diseases. 165: 251-255.
110. Hu DJ, Vanichseni S, Mastro TD, Raktham S, Young NL, Mock PA, Subbarao S, Parekh BS, Srisuwanvilai L, Sutthent R, Wasi C, Heneine W, Choopanya K. (2001). Viral load differences in early infection with two HIV-1 subtypes. AIDS. 15: 683-691.
111. Hunter DJ. (1993). AIDS in sub-Saharan Africa: the epidemiology of heterosexual transmission and the prospects for prevention. Epidemiology. 4: 63-72.
112. Hussain LA, Lehner T. (1995). Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology. 85: 475-484.
113. Investing in a comprehensive health sector response to HIV/AIDS: Scaling up treatment and Accelerating Prevention. (2004), World Health Organization: Geneva.
114. Jacobson DL, Peralta L, Farmer M, Graham NM, Wright TC, Zenilman J. (1999). Cervical ectopy and the transformation zone measured by computerized planimetry in adolescents. International Journal of Gynaecology and Obstetrics 66: 7-17.
115. Jacquez JA, Koopman JS, Simon CP, Longini IM, Jr. (1994). Role of the primary infection in epidemics of HIV infection in gay cohorts. Journal of Acquired Immune Deficiency Syndromes. 7: 1169-1184.
116. Jeffries E, Willoughby B, Boyko WJ, Schechter MT, Wiggs B, Fay S, O'Shaughnessy M. (1985). The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody. Canadian Medical Association Journal. 132: 1373-1377.
117. John GC, Nduati RW, Mbori-Ngacha D, Overbaugh J, Welch M, Richardson BA, Ndinya-Achola J, Bwayo J, Krieger J, Onyango F, Kreiss JK. (1997). Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. Journal of Infectious Diseases. 175: 57-62.
118. Kahn JO, Walker BD. (1998). Acute human immunodeficiency virus type 1 infection. New England Journal of Medicine. 339: 33-39.
119. Kalichman SC, Cage M, Barnett T, Tharnish P, Rompa D, Austin J, Luke W, O'Mowrey J, Schinazi RF. (2001). Human immunodeficiency virus in semen and plasma: investigation of sexual transmission risk behavioral correlates. AIDS Research and Human Retroviruses. 17: 1695-1703.
120. Kamali A, Quigley M, Nakiyingi J, Kinsman J, Kengeya-Kayondo J, Gopal R, Ojwiya A, Hughes P, Carpenter LM, Whitworth J. (2003). Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet. 361: 645-652.
121. Kapiga SH, Lyamuya EF, Lwihula GK, Hunter DJ. (1999). The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. AIDS. 12: 75-84.
122. Kaplan EH. (1990). Modeling HIV infectivity: must sex acts be counted? Journal of Acquired Immune Deficiency Syndromes. 3: 55-61.
123. Kashuba AD, Dyer JR, Kramer LM, Raasch RH, Eron JJ, Cohen MS. (1999). Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1. Antimicrobial Agents and Chemotherapy. 43: 1817-1826.
124. Kassler WJ, Zenilman JM, Erickson B, Fox R, Peterman TA, Hook EW, 3rd. (1994). Seroconversion in patients attending sexually transmitted disease clinics. AIDS. 8: 351-355.
125. Keet IP, Lee FK, van Griensven GJ, Lange JM, Nahmias A, Coutinho RA. (1990). Herpes simplex virus type 2 and other genital ulcerative infections as a risk factor for HIV-1 acquisition. Genitourinary Medicine. 66: 330-333.
126. Kinloch-De Loes S, Hirschel BJ, Hoen B, Cooper DA, Tindall B, Carr A, Saurat JH, Clumeck N, Lazzarin A, Mathiesen L, Raffi F, Antunes F, Von Overbeck J, Luthy R, Glauser M, Hawkins D, Baumberger C, Yerly S, Perneger T, Perrin L. (1995). A controlled trial of zidovudine in primary human immunodeficiency virus infection. New England Journal of Medicine. 333: 408-413.
127. Koelle DM, Abbo H, Peck A, Ziegweid K, Corey L. (1994). Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions. Journal of Infectious Diseases. 169: 956-961.
128. Koning FA, Jansen CA, Dekker J, Kaslow RA, Dukers N, van Baarle D, Prins M, Schuitemaker H. (2004). Correlates of resistance to HIV-1 infection in homosexual men with high-risk sexual behaviour. AIDS. 18: 1117-1126.
129. Koopman JS, Jacquez JA, Welch GW, Simon CP, Foxman B, Pollock SM, Barth-Jones D, Adams AL, Lange K. (1997). The role of early HIV infection in the spread of HIV through populations. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 14: 249-258.
130. Kovacs A, Wasserman SS, Burns D, Wright DJ, Cohn J, Landay A, Weber K, Cohen M, Levine A, Minkoff H, Miotti P, Palefsky J, Young M, Reichelderfer P. (2001). Determinants of HIV-1 shedding in the genital tract of women. Lancet. 358: 1593-1601.
131. Kreiss J, Ngugi E, Holmes K, Ndinya-Achola J, Waiyaki P, Roberts PL, Ruminjo I, Sajabi R, Kimata J, Fleming TR, Anzala A, Holton D, Plummer F. (1992). Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA. 268: 477-482.
132. Kreiss J, Willerford DM, Hensel M, Emonyi W, Plummer F, Ndinya-Achola J, Roberts PL, Hoskyn J, Hillier S, Kiviat N. (1994). Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. Journal of Infectious Diseases. 170: 1597-1601.
133. Kreiss JK, Coombs R, Plummer F, Holmes KK, Nikora B, Cameron W, Ngugi E, Ndinya Achola JO, Corey L. (1989). Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. Journal of Infectious Diseases. 160: 380-384.
134. Krieger JN, Coombs RW, Collier AC, Ho DD, Ross SO, Zeh JE, Corey L. (1995). Intermittent shedding of human immunodeficiency virus in semen: implications for sexual transmission. J Urol. 154: 1035-1040.
135. Krieger JN, Coombs RW, Collier AC, Ross SO, Chaloupka K, Cummings DK, Murphy VL, Corey L. (1991). Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy. Journal of Infectious Diseases. 163: 386-388.
136. Krieger JN, Coombs RW, Collier AC, Ross SO, Speck C, Corey L. (1995). Seminal shedding of human immunodeficiency virus type 1 and human cytomegalovirus: evidence for different immunologic controls. Journal of Infectious Diseases. 171: 1018-1022.
137. Kroodsma KL, Kozal MJ, Hamed KA, Winters MA, Merigan TC. (1994). Detection of drug resistance mutations in the human immunodeficiency virus type 1 (HIV-1) pol gene: differences in semen and blood HIV-1 RNA and proviral DNA. Journal of Infectious Diseases. 170: 1292-1295.
138. Kroon FP, Van Furth R, Bruisten SM. (1996). The effects of immunization in human immunodeficiency virus type 1 infection. New England Journal of Medicine. 335: 817-818; author reply 818-819.
139. Kucera LS, Leake E, Iyer N, Raben D, Myrvik QN. (1990). Human
140. Kuhn L, Denny L, Pollack AE, Wright TC. (1999). Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera. Contraception. 59: 363-367.
141. Kuiken CL, van Griensven GJ, de Vroome EM, Coutinho RA. (1990). Risk factors and changes in sexual behavior in male homosexuals who seroconverted for human immunodeficiency virus antibodies. American Journal of Epidemiology. 132: 523-530.
142. Kunanusont C, Foy HM, Kreiss JK, Rerks-Ngarm S, Phanuphak P, Raktham S, Pau CP, Young NL. (1995). HIV-1 subtypes and male-to-female transmission in Thailand. Lancet. 345: 1078-1083.
143. Lacey CJ, Murphy ME, Sanderson MJ, Monteiro EF, Vail A, Schorah CJ. (1996). Antioxidant-micronutrients and HIV infection. International Journal of STD and AIDS. 7: 485-489.
144. Lafeuillade A, Solas C, Halfon P, Chadapaud S, Hittinger G, Lacarelle B. (2002). Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations. HIV Clin Trials. 3: 27-35.
145. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, Goeman J, Behets F, Batter V, Alary M. (1993). Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS. 7: 95-102.
146. Lampinen TM, Critchlow CW, Kuypers JM, Hurt CS, Nelson PJ, Hawes SE, Coombs RW, Holmes KK, Kiviat NB. (2000). Association of antiretroviral therapy with detection of HIV-1 RNA and DNA in the anorectal mucosa of homosexual men. AIDS. 14: F69-75.
147. Lavreys L, Baeten JM, Martin HL, Jr, Overbaugh J, Mandaliya K, Ndinya-Achola J, Kreiss JK. (2004). Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study. AIDS. 18: 695-697.
148. Law MG, Prestage G, Grulich A, Van de Ven P, Kippax S. (2001). Modelling the effect of combination antiretroviral treatments on HIV incidence. AIDS. 15: 1287-1294.
149. Lawn SD, Shattock RJ, Acheampong JW, Lal RB, Folks TM, Griffin GE, Butera ST. (1999). Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans. AIDS. 13: 2231-2237.
150. Lazzarin A, Saracco A, Musicco M, Nicolosi A. (1991). Man-to-woman sexual transmission of the human immunodeficiency virus. Risk factors related to sexual behavior, man's infectiousness, and woman's susceptibility. Italian Study Group on HIV Heterosexual Transmission. Archives of Internal Medicine. 151: 2411-2416.
151. Lee MK, Heaton J, Cho MW. (1999). Identification of determinants of interaction between CXCR4 and gp120 of a dual-tropic HlV-1DH12 isolate. Virology. 257: 290-296.
152. Lee TH, Sakahara N, Fiebig E, Busch MP, O'Brien TR, Herman SA. (1996). Correlation of HIV-1 RNA levels in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 12: 427-428.
153. Lehner T, Hussain L, Wilson J, Chapman M. (1991). Mucosal transmission of HIV. Nature. 353: 709.
154. Leruez-Ville M, Dulioust E, Costabliola D, Salmon D, Tachet A, Finkielsztejn L, De Almeida M, Silbermann B, Sicard D, Jouannet P, Rouzioux C. (2002). Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: an 18 month longitudinal study (ANRS EP012). AIDS. 16: 486-488.
155. Lindback S, Karlsson AC, Mittler J, Blaxhult A, Carlsson M, Briheim G, Sonnerborg A, Gaines H. (2000). Viral dynamics in primary HIV-1 infection. Karolinska Institutet Primary HIV Infection Study Group. AIDS. 14: 2283-2291.
156. Liuzzi G, Chirianni A, Bagnarelli P, Clementi M, Piazza M. (1999). A combination of nucleoside analogues and a protease inhibitor reduces HIV-1 RNA levels in semen: implications for sexual transmission of HIV infection. Antiviral Therapy. 4: 95-99.
157. Liuzzi G, Chirianni A, Clementi M, Bagnarelli P, Valenza A, Cataldo PT, Piazza M. (1996). Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS. 10: F51-56.
158. Liuzzi G, D'Offizi G, Topino S, Zaccarelli M, Amendola A, Capobianchi MR, Perno CF, Narciso P, Antinori A. (2003). Dynamics of viral load rebound in plasma and semen after stopping effective antiretroviral therapy. AIDS. 17: 1089-1092.
159. Look MP, Rockstroh JK, Rao GS, Barton S, Lemoch H, Kaiser R, Kupfer B, Sudhop T, Spengler U, Sauerbruch T. (1998). Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot study. European Journal of Clinical Investigation. 28: 389-397.
160. Low-Beer S, Weber AE, Bartholomew K, Landolt M, Oram D, Montaner JS, O'Shaughnessy MV, Hogg RS. (2000). A reality check: the cost of making post-exposure prophylaxis available to gay and bisexual men at high sexual risk. AIDS. 14: 325-326.
161. Lurie P, Miller S, Hecht F, Chesney M, Lo B. (1998). Postexposure prophylaxis after nonoccupational HIV exposure: clinical, ethical, and policy considerations. JAMA. 280: 1769-1773.
162. Mackewicz C, Levy JA. (1992). CD8+ cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Research and Human Retroviruses. 8: 1039-1050.
163. Magro CM, Crowson AN, Alfa M, Nath A, Ronald A, Ndinya-Achola JO, Nasio J. (1996). A morphological study of penile chancroid lesions in human immunodeficiency virus (HIV)-positive and -negative African men with a hypothesis concerning the role of chancroid in HIV transmission. Human Pathology. 27: 1066-1070.
164. Margolis DM, Ostrove JM, Straus SE. (1993). HSV-1 activation of HIV-1 transcription is augmented by a cellular protein that binds near the initiator element. Virology. 192: 370-374.
165. Margolis DM, Rabson AB, Straus SE, Ostrove JM. (1992). Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes. Virology. 186: 788-791.
166. Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, Lackner AA, Mahoney CJ, Miller CJ, Claypool LE, Ho DD, Alexander NJ. (1996). Progesterone implants enhance SIV vaginal transmission and early virus load. Nature Medicine. 2: 1084-1089.
167. Mastro TD, de Vincenzi I. (1996). Probabilities of sexual HIV-1 transmission. AIDS. 10 Suppl A: S75-82.
168. Mastro TD, Kitayaporn D. (1998). HIV type 1 transmission probabilities: estimates from epidemiological studies. AIDS Research and Human Retroviruses. 14 Suppl 3: S223-227.
169. Mastro TD, Satten GA, Nopkesorn T, Sangkharomya S, Longini IM, Jr. (1994). Probability of female-to-male transmission of HIV-1 in Thailand. Lancet. 343: 204-207.
170. Mati JK, Hunter DJ, Maggwa BN, Tukei PM. (1995). Contraceptive use and the risk of HIV infection in Nairobi, Kenya. International Journal of Gynaecology and Obstetrics 48: 61-67.
171. Mayer KH, Boswell S, Goldstein R, Lo W, Xu C, Tucker L, DePasquale MP, D'Aquila R, Anderson DJ. (1999). Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. Clinical Infectious Diseases. 28: 1252-1259.
172. Mbizvo MT, Adamchak DJ. (1989). Condom use and acceptance: a survey of male Zimbabweans. Central African Journal of Medicine. 35: 519-523.
173. Mbopi Keou FX, Gresenguet G, Mayaud P, Weiss HA, Gopal R, Brown DW, Hayes RJ, Mabey DC, Belec L. (1999). Genital herpes simplex virus type 2 shedding is increased in HIV-infected women in Africa. AIDS. 13: 536-537.
174. McClelland RS, Wang CC, Overbaugh J, Richardson BA, Corey L, Ashley RL, Mandaliya K, Ndinya-Achola J, Bwayo JJ, Kreiss JK. (2002). Association between cervical shedding of herpes simplex virus and HIV-1. AIDS. 16: 2425-2430.
175. McMichael A, Hanke T. (2002). The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible? Nature Reviews Immunology. 2: 283-291.
176. Mehendale SM, Rodrigues JJ, Brookmeyer RS, Gangakhedkar RR, Divekar AD, Gokhale MR, Risbud AR, Paranjape RS, Shepherd ME, Rompallo AE. (1995). Incidence and predictors of human immunodeficiency virus type 1 seroconversion in patients attending sexually transmitted disease clinics in India. Journal of Infectious Diseases. 172: 1486-1491.
177. Mellors JW, Kingsley LA, Rinaldo CR, Jr., Todd JA, Hoo BS, Kokka RP, Gupta P. (1995). Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Annals of Internal Medicine. 122: 573-579.
178. Merigan TC. (1998) Use of PCR to measure HIV viral changes in drug-resistant genes in genital fluids. Journal of Reproductive Immunology. 41: 177-185.
179. Mermin JH, Holodniy M, Katzenstein DA, Merigan TC. (1991). Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction. Journal of Infectious Diseases. 164: 769-772.
180. Mertz KJ, Trees D, Levine WC, Lewis JS, Litchfield B, Pettus KS, Morse SA, St Louis ME, Weiss JB, Schwebke J, Dickes J, Kee R, Reynolds J, Hutcheson D, Green D, Dyer I, Richwald GA, Novotny J, Weisfuse I, Goldberg M, O'Donnell JA, Knaup R. (1998). Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The Genital Ulcer Disease Surveillance Group. Journal of Infectious Diseases. 178: 1795-1798.
181. Moench TR, Chipato T, Padian NS. (2001). Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices. AIDS. 15: 1595-1602.
182. Mole L, Ripich S, Margolis D, Holodniy M. (1997). The impact of active herpes simplex virus infection on human immunodeficiency virus load. Journal of Infectious Diseases. 176: 766-770.
183. Montano MA, Nixon CP, Ndung'u T, Bussmann H, Novitsky VA, Dickman D, Essex M. (2000). Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-kappaB enhancer gain-of-function. Journal of Infectious Diseases. 181: 76-81.
184. Moriuchi M, Moriuchi H, Williams R, Straus SE. (2000). Herpes simplex virus infection induces replication of human immunodeficiency virus type 1. Virology. 278: 534-540.
185. Morse SA. (1999). Etiology of genital ulcer disease and its relationship to HIV infection. Sexually Transmitted Diseases. 26: 63-65.
186. Moses S, Bailey RC, Ronald AR. (1998). Male circumcision: assessment of health benefits and risks. Sexually Transmitted Infections. 74: 368-373.
187. Moses S, Plummer FA, Bradley JE, Ndinya-Achola JO, Nagelkerke NJ, Ronald AR. (1994), The association between lack of male circumcision and risk for HIV infection: a review of the epidemiological data. Sexually Transmitted Diseases. 21: 201-210.
188. Moss AR, Osmond D, Bacchetti P, Chermann JC, Barre-Sinoussi F, Carlson J. (1987). Risk factors for AIDS and HIV seropositivity in homosexual men. American Journal of Epidemiology. 125: 1035-1047.
189. Moss GB, Clemetson D, D'Costa L, Plummer FA, Ndinya-Achola JO, Reilly M, Holmes KK, Piot P, Maitha GM, Hillier SL. (1991). Association of cervical ectopy with heterosexual transmission of human immunodeficiency virus: results of a study of couples in Nairobi, Kenya. Journal of Infectious Diseases. 164: 588-591.
190. Moss GB, Overbaugh J, Welch M, Reilly M, Bwayo J, Plummer FA, Ndinya-Achola JO, Malisa MA, Kreiss JK. (1995). Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4 cell depletion. Journal of Infectious Diseases. 172: 1469-1474.
191. Mostad SB, Jackson S, Overbaugh J, Reilly M, Chohan B, Mandaliya K, Nyange P, Ndinya-Achola J, Bwayo JJ, Kreiss JK. (1998). Cervical and vaginal shedding of human immunodeficiency virus type 1-infected cells throughout the menstrual cycle. Journal of Infectious Diseases. 178: 983-991.
192. Mostad SB, Overbaugh J, DeVange DM, Welch MJ, Chohan B, Mandaliya K, Nyange P, Martin HL, Jr, Ndinya-Achola J, Bwayo JJ, Kreiss JK. (1997). Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet. 350: 922-927.
193. Musicco M, Lazzarin A, Nicolosi A, Gasparini M, Costigliola P, Arici C, Saracco A. (1994). Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission. Archives of Internal Medicine. 154: 1971-1976.
194. Nelson KE, Eiumtrakul S, Celentano D, Maclean I, Ronald A, Suprasert S, Hoover DR, Kuntolbutra S, Zenilman JM. (1997). The association of herpes simplex virus type 2 (HSV-2), Haemophilus ducreyi, and syphilis with HIV infection in young men in northern Thailand. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 16: 293-300.
195. Nicolosi A, Correa Leite ML, Musicco M, Arici C, Gavazzeni G, Lazzarin A. (1994). The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: a study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission. Epidemiology. 5: 570-575.
196. Nicolosi A, Musicco M, Saracco A, Lazzarin A. (1994). Risk factors for woman-to-man sexual transmission of the human immunodeficiency virus. Italian Study Group on HIV Heterosexual Transmission. Journal of Acquired Immune Deficiency Syndromes. 7: 296-300.
197. Nopkesorn T, Mock PA, Mastro TD, Sangkharomya S, Sweat M, Limpakarnjanarat K, Laosakkitiboran J, Young NL, Morse SA, Schmid S, Weniger BG. (1998). HIV-1 subtype E incidence and sexually transmitted diseases in a cohort of military conscripts in northern Thailand. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 18: 372-379.
198. Novitsky VA, Montano MA, McLane MF, Renjifo B, Vannberg F, Foley BT, Ndung'u TP, Rahman M, Makhema MJ, Marlink R, Essex M. (1999). Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana. Journal of Virology. 73: 4427-4432.
199. Nunnari G, Otero M, Dornadula G, Vanella M, Zhang H, Frank I, Pomerantz RJ. (2002). Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections. AIDS. 16: 39-45.
200. Nuovo GJ, Forde A, MacConnell P, Fahrenwald R. (1993). In situ detection of PCR-amplified HIV-1 nucleic acids and tumor necrosis factor cDNA in cervical tissues. American Journal of Pathology. 143: 40-48.
201. O'Brien TR, Busch MP, Donegan E, Ward JW, Wong L, Samson SM, Perkins HA, Altman R, Stoneburner RL, Holmberg SD. (1994). Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners. Journal of Acquired Immune Deficiency Syndromes. 7: 705-710.
202. O'Brien WA, Grovit-Ferbas K, Namazi A, Ovcak-Derzic S, Wang HJ, Park J, Yeramian C, Mao SH, Zack JA. (1995). Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood. 86: 1082-1089.
203. Oelrichs R. (2003). Basic HIV virology. In HIV Management in Australasia., J Hoy S Lewin, eds. (Sydney: Australasian Society for HIV Medicine), pp. 9-22.
204. O'Farrell N. (2001). Enhanced efficiency of female-to-male HIV transmission in core groups in developing countries: the need to target men. Sexually Transmitted Diseases. 28: 84-91.
205. O'Farrell N. (1995). Global eradication of donovanosis: an opportunity for limiting the spread of HIV-1 infection. Genitourinary Medicine. 71: 27-31.
206. Osmanov S, Pattou C, Walker N, Schwardlander B, Esparza J. (2002). Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. Journal of Acquired Immune Deficiency Syndromes. 29: 184-190.
207. Osmond D, Bacchetti P, Chaisson RE, Kelly T, Stempel R, Carlson J, Moss AR. (1988). Time of exposure and risk of HIV infection in homosexual partners of men with AIDS. American Journal of Public Health. 78: 944-948.
208. Otten MW, Jr, Zaidi AA, Peterman TA, Rolfs RT, Witte JJ. (1994). High rate of HIV seroconversion among patients attending urban sexually transmitted disease clinics. AIDS. 8: 549-553.
209. Overbaugh J, Bangham CR. (2001). Selection forces and constraints on retroviral sequence variation. Science. 292: 1106-1109.
210. Padian NS, Shiboski SC, Jewell NP. (1990). The effect of number of exposures on the risk of heterosexual HIV transmission. Journal of Infectious Diseases. 161: 883-887.
211. Padian NS, Vittinghoff E, Shiboski S. (1994). Heterosexual transmission of HIV. New England Journal of Medicine. 331: 1718; author reply 1718-1719.
212. Paxton WA, Liu R, Kang S, Wu L, Gingeras TR, Landau NR, Mackay CR, Koup RA. (1998). Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines. Virology. 244: 66-73.
213. Pereira AS, Kashuba AD, Fiscus SA, Hall JE, Tidwell RR, Troiani L, Dunn JA, Eron JJ, Jr, Cohen MS. (1999). Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden. Journal of Infectious Diseases. 180: 2039-2043.
214. Phillips DM, Sudol KM, Taylor CL, Guichard L, Elsen R, Maguire RA. (2004). Lubricants containing N-9 may enhance rectal transmission of HIV and other STIs. Contraception. 70: 107-110.
215. Pilcher CD, Eron JJ, Jr, Vemazza PL, Battegay M, Harr T, Yerly S, Vom S, Perrin L. (2001). Sexual transmission during the incubation period of primary HIV infection. JAMA. 286: 1713-1714.
216. Pilcher CD, Shugars DC, Fiscus SA, Miller WC, Menezes P, Giner J, Dean B, Robertson K, Hart CE, Lennox JL, Eron JJ, Jr., Hicks CB. (2001). HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS. 15: 837-845.
217. Pilcher CD, Tien HC, Eron JJ, Jr, Vernazza PL, Leu SY, Stewart PW, Goh LE, Cohen MS. (2004). Brief but efficient: acute HIV infection and the sexual transmission of HIV. Journal of Infectious Diseases. 189: 1785-1792.
218. Plourde PJ, Pepin J, Agoki E, Ronald AR, Ombette J, Tyndall M, Cheang M, Ndinya-Achola JO, D'Costa LJ, Plummer FA. (1994). Human immunodeficiency virus type 1 seroconversion in women with genital ulcers. Journal of Infectious Diseases. 170: 313-317.
219. Plummer FA, Simonsen JN, Cameron DW, Ndinya-Achola JO, Kreiss JK, Gakinya MN, Waiyaki P, Cheang M, Piot P, Ronald AR. (1991). Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. Journal of Infectious Diseases. 163: 233-239.
220. Pope M, Haase AT. (2003). Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nature Medicine. 9: 847-852.
221. Posavad CM, Wald A, Kuntz S, Huang ML, Selke S, Krantz E, Corey L. (2004). Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy. Journal of Infectious Diseases. 190: 693-696.
222. Pozniak A. (2004). Post-exposure prophylaxis for sexual exposure to HIV. Current Opinion in Infectious Diseases. 17: 39-40.
223. Quigley MA, Weiss HA, Hayes RJ. (2001). Male circumcision as a measure to control HIV infection and other sexually transmitted diseases. Current Opinion in Infectious Diseases. 14: 71-75.
224. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, Meehan MO, Lutalo T, Gray RH. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. New England Journal of Medicine. 342: 921-929.
225. Ragni MV, Faruki H, Kingsley LA. (1998). Heterosexual HIV-1 transmission and viral load in hemophilic patients. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 17: 42-45.
226. Rappersberger K, Gartner S, Schenk P, Stingl G, Groh V, Tschachler E, Mann DL, Wolff K, Konrad K, Popovic M. (1988). Langerhans' cells are an actual site of HIV-1 replication. Intervirology. 29: 185-194.
227. Raudrant D, Frappart L, De Haas P, Thoulon JM, Charvet F. (1989). Study of the vaginal mucous membrane following tampon utilisation; aspect on colposcopy, scanning electron microscopy and transmission electron microscopy. European Journal of Obstetrics, Gynecology, and Reproductive Biology 31: 53-65.
228. Reddy YS, Gotzkowsky SK, Eron JJ, Kim JY, Fiske WD, Fiscus SA, Petch L, Cohen MS, Kashuba AD. (2002). Pharmacokinetic and pharmacodynamic investigation of efavirenz in the semen and blood of human immunodeficiency virus type 1-infected men. Journal of Infectious Diseases. 186: 1339-1343.
229. Resistance UCGoMtToHD. (2001). Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom. BMJ. 322: 1087-1088.
230. Reynolds SJ, Risbud AR, Shepherd ME, Zenilman JM, Brookmeyer RS, Paranjape RS, Divekar AD, Gangakhedkar RR, Ghate MV, Bollinger RC, Mehendale SM. (2003). Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. Journal of Infectious Diseases. 187: 1513-1521.
231. Robinson HL. (2002). New hope for an AIDS vaccine. Nature Reviews Immunology. 2: 239-250.
232. Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Weir SS, Wong EL. (1998). A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. New England Journal of Medicine. 339: 504-510.
233. Rosenstein IJ, Stafford MK, Kitchen VS, Ward H, Weber JN, Taylor-Robinson D. (1998). Effect on normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1. Journal of Infectious Diseases. 177: 1386-1390.
234. Rotchford K, Strum AW, Wilkinson D. (2000). Effect of coinfection with STDs and of STD treatment on HIV shedding in genital-tract secretions: systematic review and data synthesis. Sexually Transmitted Diseases. 27: 243-248.
235. Rottingen JA, Cameron DW, Garnett GP. (2001). A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sexually Transmitted Diseases. 28: 579-597.
236. Royce RA, Sena A, Cates W, Jr, Cohen MS. (1997). Sexual transmission of HIV. New England Journal of Medicine. 336: 1072-1078.
237. Rozenbaum W, Gharakhanian S, Cardon B, Duval E, Coulaud JP. (1988). HIV transmission by oral sex. Lancet. 1: 1395.
238. Safety of nonoxynol-9 when used for contraception. (2001), vol. 2004, World Health Organisation.
239. Sandstrom PA, Murray J, Folks TM, Diamond AM. (1998). Antioxidant defenses influence HIV-1 replication and associated cytopathic effects. Free Radical Biology & Medicine. 24: 1485-1491.
240. Sappey C, Leclercq P, Coudray C, Faure P, Micoud M, Favier A. (1994). Vitamin, trace element and peroxide status in HIV seropositive patients: asymptomatic patients present a severe beta-carotene deficiency. Clinica chimica acta. 230: 35-42.
241. Schacker T. (2001). The role of HSV in the transmission and progression of HIV. Herpes. 8: 46-49.
242. Schacker T, Collier AC, Hughes J, Shea T, Corey L. (1996). Clinical and epidemiologic features of primary HIV infection. Annals of Internal Medicine. 125: 257-264.
243. Schacker T, Hu HL, Koelle DM, Zeh J, Saltzman R, Boon R, Shaughnessy M, Barnum G, Corey L. (1998). Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial. Annals of Internal Medicine. 128: 21-28.
244. Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaughnessy M, Corey L. (1998). Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA. 280: 61-66.
245. Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L. (2002). Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. Journal of Infectious Diseases. 186: 1718-1725.
246. Schacker T, Zeh J, Hu HL, Hill E, Corey L. (1998). Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. Journal of Infectious Diseases. 178: 1616-1622.
247. Schockmel GA, Balavoine JF, Yerly S, Perrin L. (1998). Use of highly sensitive assays for the evaluation of post-exposure HIV prophylaxis. AIDS. 12: 1726-1727.
248. Seage GR, 3rd, Mayer KH, Horsburgh CR, Jr. (1993). Risk of human immunodeficiency virus infection from unprotected receptive anal intercourse increases with decline in immunologic status of infected partners. American Journal of Epidemiology. 137: 899-908.
249. Seidlin M, Vogler M, Lee E, Lee YS, Dubin N. (1993). Heterosexual transmission of HIV in a cohort of couples in New York City. AIDS. 7: 1247-1254.
250. Semba RD, Lyles CM, Margolick JB, Caiaffa WT, Farzadegan H, Cohn S, Vlahov D. (1998). Vitamin A supplementation and human immunodeficiency virus load in injection drug users. Journal of Infectious Diseases. 177: 611-616.
251. Serwadda D, Gray RH, Sewankambo NK, Wabwire-Mangen F, Chen MZ, Quinn TC, Lutalo T, Kiwanuka N, Kigozi G, Nalugoda F, Meehan MP, Ashley Morrow R, Wawer MJ. (2003). Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. Journal of Infectious Diseases. 188: 1492-1497.
252. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, Wabwire-Mangen F, Serwadda D, Li C, Kiwanuka N, Hillier SL, Rabe L, Gaydos CA, Quinn TC, Konde-Lule J. (1997). HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet. 350: 546-550.
253. Si-Mohamed A, Kazatchkine MD, Heard I, Goujon C, Prazuck T, Aymard G, Cessot G, Kuo YH, Bernard MC, Diquet B, Malkin JE, Gutmann L, Belec L. (2000). Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy. Journal of Infectious Diseases. 182: 112-122.
254. Soto-Ramirez LE, Renjifo B, McLane MF, Marlink R, O'Hara C, Sutthent R, Wasi C, Vithayasai P, Vithayasai V, Apichartpiyakul C, Auewarakul P, Pena Cruz V, Chui DS, Osathanondh R, Mayer K, Lee TH, Essex M. (1996). HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science. 271: 1291-1293.
255. Speck CE, Coombs RW, Koutsky LA, Zeh J, Ross SO, Hooton TM, Collier AC, Corey L, Cent A, Dragavon J, Lee W, Johnson EJ, Sampoleo RR, Krieger JN. (1999). Risk factors for HIV-1 shedding in semen. American Journal of Epidemiology. 150: 622-631.
256. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL. (1996). Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. New England Journal of Medicine. 335: 1621-1629.
257. Spitzer PG, Weiner NJ. (1989). Transmission of HIV infection from a woman to a man by oral sex. New England Journal of Medicine. 320: 251.
258. Stafford MK, Ward H, Flanagan A, Rosenstein IJ, Taylor-Robinson D, Smith JR, Weber J, Kitchen VS. (1998). Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 17: 327-331.
259. Stamm WE, Handsfield HH, Rompalo AM, Ashley RL, Roberts PL, Corey L. (1988). The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA. 260: 1429-1433.
260. Stranford SA, Skurnick J, Louria D, Osmond D, Chang SY, Sninsky J, Ferrari G, Weinhold K, Lindquist C, Levy JA. (1999). Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. Proceedings of the National Academy of Sciences of the United States of America. 96: 1030-1035.
261. Sturm-Ramirez K, Gaye-Diallo A, Eisen G, Mboup S, Kanki PJ. (2000). High levels of tumor necrosis factor-alpha and interleukin-1beta in bacterial vaginosis may increase susceptibility to human immunodeficiency virus. Journal of Infectious Diseases. 182: 467-473.
262. Sulkowski MS, Chaisson RE, Karp CL, Moore RD, Margolick JB, Quinn TC. (1998). The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults. Journal of Infectious Diseases. 178: 1642-1648.
263. Sullivan AK, Atkins MC, Boag F. (1997). Factors facilitating the sexual transmission of HIV-1. AIDS Patient Care and STDS. 11: 167-177.
264. Tachet A, Dulioust E, Salmon D, De Almeida M, Rivalland S, Finkielsztejn L, Heard I, Jouannet P, Sicard D, Rouzioux C. (1999). Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS. 13: 823-831.
265. Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, Yang LP, Liomba GN, Broadhead RL, Chiphangwi JD, Miotti PG. (1998). Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS. 12: 1699-1706.
266. Taylor S, Back DJ, Drake SM, Workman J, Reynolds H, Gibbons SE, White DJ, Pillay D. (2001). Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir. Journal of Antimicrobial Chemotherapy. 48: 351-354.
267. Taylor S, Back DJ, Workman J, Drake SM, White DJ, Choudhury B, Cane PA, Beards GM, Halifax K, Pillay D. (1999). Poor penetration of the male genital tract by HIV-1 protease inhibitors. AIDS. 13: 859-860.
268. Taylor S, Boffito M, Vernazza PL. (2003). Antiretroviral therapy to reduce the sexual transmission of HIV. Journal of HIV Therapy. 8: 55-66.
269. Taylor S, Drake S. (2000). HIV in semen: clinical implications. Journal of HIV Therapy. 5: 18-25.
270. Taylor S, Reynolds H, Sabin CA, Drake SM, White DJ, Back DJ, Pillay D. (2001). Penetration of efavirenz into the male genital tract: drug concentrations and antiviral activity in semen and blood of HIV-1-infected men. AIDS. 15: 2051-2053.
271. Taylor S, Sadiq ST, Weller I, Kaye S, Workman J, Cane PA, Bennett J, Copas AJ, Drake SM, Pillay D. (2003). Drug-resistant HIV-1 in the semen of men receiving antiretroviral therapy with acute sexually transmitted infections. Antiviral Therapy. 8: 479-483.
272. Telzak EE, Chiasson MA, Bevier PJ, Stoneburner RL, Castro KG, Jaffe HW. (1993). HIV-1 seroconversion in patients with and without genital ulcer disease. A prospective study. Annals of Internal Medicine. 119: 1181-1186.
273. Theus SA, Harrich DA, Gaynor R, Radolf JD, Norgard MV. (1998). Treponema pallidum, lipoproteins, and synthetic lipoprotein analogues induce human immunodeficiency virus type 1 gene expression in monocytes via NF-kappaB activation. Journal of Infectious Diseases. 177: 941-950.
274. Tindall B, Evans L, Cunningham P, McQueen P, Hurren L, Vasak E, Mooney J, Cooper DA. (1992). Identification of HIV-1 in semen following primary HIV-1 infection. AIDS. 6: 949-952.
275. Tovanabutra S, Robison V, Wongtrakul J, Sennum S, Suriyanon V, Kingkeow D, Kawichai S, Tanan P, Duerr A, Nelson KE. (2002). Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand. Journal of Acquired Immune Deficiency Syndromes. 29: 275-283.
276. Trussell J, Kost K. (1987). Contraceptive failure in the United States: a critical review of the literature. Studies in Family Planning. 18: 237-283.
277. Tsai CC, Emau P, Follis KE, Beck TW, Benveniste RE, Bischofberger N, Lifson JD, Morton WR. (1998). Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. Journal of Virology. 72: 4265-4273.
278. Uckun FM, D'Cruz OJ. (1999). Prophylactic contraceptives for HIV/AIDS. Human Reproduction Update. 5: 506-514.
279. Van Damme L, Ramjee G, Alary M, Vuylsteke B, Chandeying V, Rees H, Sirivongrangson P, Mukenge-Tshibaka L, Ettiegne-Traore V, Uaheowitchai C, Karim SS, Masse B, Perriens J, Laga M. (2002). Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 360: 971-977.
280. Van Howe RS. (1999). Circumcision and HIV infection: review of the literature and meta-analysis. International Journal of STD and AIDS. 10: 8-16.
281. Van Laer L, Vingerhoets J, Vanham G, Kestens L, Bwayo J, Otido J, Piot P, Roggen E. (1995). In vitro stimulation of peripheral blood mononuclear cells (PBMC) from HIV- and HIV+ chancroid patients by Haemophilus ducreyi antigens. Clinical and Experimental Immunology. 102: 243-250.
282. Vernazza PL, Dyer JR, Fiscus SA, Eron JJ, Cohen MS. (1997). HIV-1 viral load in blood, semen and saliva. AIDS. 11: 1058-1059.
283. Vernazza PL, Eron JJ, Cohen MS, van der Horst CM, Troiani L, Fiscus SA. (1994). Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS. 8: 1325-1329.
284. Vernazza PL, Eron JJ, Fiscus SA, Cohen MS. (1999). Sexual transmission of HIV: infectiousness and prevention. AIDS. 13: 155-166.
285. Vernazza PL, Gilliam BL, Dyer J, Fiscus SA, Eron JJ, Frank AC, Cohen MS. (1997). Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS. 11: 987-993.
286. Vernazza PL, Gilliam BL, Flepp M, Dyer JR, Frank AC, Fiscus SA, Cohen MS, Eron JJ. (1997). Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS. 11: 1249-1254.
287. Vernazza PL, Grunow R, Dyer JR, Pichler W. (1997). Nontransmission of HIV: a multifactorial phenomenon. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 14: 295-296.
288. Vernazza PL, Troiani L, Flepp MJ, Cone RW, Schock J, Roth F, Boggian K, Cohen MS, Fiscus SA, Eron JJ. (2000). Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS. 14: 117-121.
289. Vogt MW, Witt DJ, Craven DE, Byington R, Crawford DF, Hutchinson MS, Schooley RT, Hirsch MS. (1987). Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome. Annals of Internal Medicine. 106: 380-382.
290. Wade NA, Birkhead GS, Warren BL, Charbonneau TT, French PT, Wang L, Baum JB, Tesoriero JM, Savicki R. (1998). Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. New England Journal of Medicine. 339: 1409-1414.
291. Wainberg MA, Beaulieu R, Tsoukas C, Thomas R. (1993). Detection of zidovudine-resistant variants of HIV-1 in genital fluids. AIDS. 7: 433-434.
292. Wald A, Link K. (2002). Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. Journal of Infectious Diseases. 185: 45-52.
293. Wald A, Zeh J, Barnum G, Davis LG, Corey L. (1996). Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Annals of Internal Medicine. 124: 8-15.
294. Wald A, Zeh J, Selke S, Ashley RL, Corey L. (1995). Virologic characteristics of subclinical and symptomatic genital herpes infections. New England Journal of Medicine. 333: 770-775.
295. Wang CC, McClelland RS, Overbaugh J, Reilly M, Panteleeff DD, Mandaliya K, Chohan B, Lavreys L, Ndinya-Achola J, Kreiss JK. (2004). The effect of hormonal contraception on genital tract shedding of HIV-1. AIDS. 18: 205-209.
296. Wang CC, Reilly M, Kreiss JK. (1999). Risk of HIV infection in oral contraceptive pill users: a meta-analysis. Journal of Acquired Immune Deficiency Syndromes. 21: 51-58.
297. Wasserheit JN. (1992). Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sexually Transmitted Diseases. 19: 61-77.
298. Wasserheit JN. (1999). HIV infection and other STDs: so close and yet so far. Sexually Transmitted Diseases. 26: 549-550.
299. Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, Kiwanuka N, Wabwire-Mangen F, Li C, Lutalo T, Nalugoda F, Gaydos CA, Moulton LH, Meehan MO, Ahmed S, Gray RH. (1999). Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet. 353: 525-535.
300. Weber JN, McCreaner A, Berrie E, Wadsworth J, Jeffries DJ, Pinching AJ, Harris JR. (1986). Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS. Genitourinary Medicine. 62: 177-180.
301. Weir SS, Feldblum PJ, Roddy RE, Zekeng L. (1994). Gonorrhea as a risk factor for HIV acquisition. AIDS. 8: 1605-1608.
302. Weir SS, Roddy RE, Zekeng L, Feldblum PJ. (1995). Nonoxynol-9 use, genital ulcers, and HIV infection in a cohort of sex workers. Genitourinary Medicine. 71: 78-81.
303. Weiss HA, Quigley MA, Hayes RJ. (2000). Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS. 14: 2361-2370.
304. Wilborn WH, Hahn DW, McGuire JJ. (1983). Scanning electron microscopy of human spermatozoa after incubation with the spermicide nonoxynol-9. Fertility and Sterility. 39: 717-719.
305. Winkelstein W, Jr, Lyman DM, Padian N, Grant R, Samuel M, Wiley JA, Anderson RE, Lang W, Riggs J, Levy JA. (1987). Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study. JAMA. 257: 321-325.
306. Winter AJ, Taylor S, Workman J, White D, Ross JD, Swan AV, Pillay D. (1999). Asymptomatic urethritis and detection of HIV-1 RNA in seminal plasma. Sexually Transmitted Infections. 75: 261-263.
307. Wittkowski KM. (1995). The potential of nonoxynol-9 for the prevention of HIV infection reconsidered. AIDS. 9: 310-311.
308. Wolff H, Mayer K, Seage G, Politch J, Horsburgh CR, Anderson D. (1992). A comparison of HIV-1 antibody classes, titers, and specificities in paired semen and blood samples from HIV-1 seropositive men. Journal of Acquired Immune Deficiency Syndromes. 5: 65-69.
309. Yerly S, Kaiser L, Race E, Bru JP, Clavel F, Perrin L. (1999). Transmission of antiretroviral-drug-resistant HIV-1 variants. Lancet. 354: 729-733.
310. Yerly S, Vora S, Rizzardi P, Chave JP, Vernazza PL, Flepp M, Telenti A, Battegay M, Veuthey AL, Bru JP, Rickenbach M, Hirschel B, Perrin L. (2001). Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS. 15: 2287-2292.
311. Zhang H, Dornadula G, Beumont M, Livornese L, Jr, Van Uitert B, Henning K, Pomerantz RJ. (1998). Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. New England Journal of Medicine. 339: 1803-1809.
312. Zhang LQ, MacKenzie P, Cleland A, Holmes EC, Brown AJ, Simmonds P. (1993). Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. Journal of Virology. 67: 3345-3356.
313. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD. (1993). Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science. 261: 1179-1181.
314. Zuckerman RA, Whittington WL, Celum CL, Collis TK, Lucchetti AJ, Sanchez JL, Hughes JP, Coombs RW. (2004). Higher concentration of HIV RNA in rectal mucosa secretions than in blood and seminal plasma, among men who have sex with men, independent of antiretroviral therapy. Journal of Infectious Diseases. 190: 156-161.